RSV Prevention in High-Risk Children

Why might some children need RSV protection for a second season?

RSV is a common respiratory virus that usually causes cold-like symptoms but can lead to bronchiolitis or pneumonia, particularly in infants and young children. Risk of severe illness is higher for some children, including those born very prematurely and those with certain chronic lung or heart conditions. The Centers for Disease Control and Prevention (CDC) advises that RSV prevention decisions depend on age, health history, and the products available for the season.

Nirsevimab is a monoclonal antibody that provides passive protection: it supplies an antibody that can block RSV from infecting cells, rather than prompting the child's immune system to make its own response as a vaccine does. Protection is time-limited, which is why a child who qualified during one RSV season may be assessed again before the next. A second dose is not automatically appropriate for every child; clinicians use current recommendations and the child's risk factors to determine eligibility.

What does real-world evidence say about nirsevimab in a second season?

MedPage Today reported meeting data suggesting that second-season nirsevimab immunization was effective at preventing RSV-related hospitalization among eligible children at high risk of severe disease. Real-world studies can help show how an intervention performs in routine care, beyond the conditions of a clinical trial. The report's summary does not provide enough detail to state a precise effect size, so the finding is best understood as supportive evidence rather than a guarantee of protection.

Hospitalization is an important outcome, but prevention does not eliminate the possibility of infection or illness. Families should still seek medical advice if a young child has difficulty breathing, signs of dehydration, unusual sleepiness, or worsening symptoms. Decisions about seasonal antibody protection should be made with the child's healthcare professional, who can review medical history and the latest local guidance.

How can families help reduce the spread of RSV?

RSV spreads through respiratory droplets and contact with contaminated hands or surfaces. Washing hands, covering coughs and sneezes, cleaning frequently touched surfaces, and avoiding close contact between infants and people with cold symptoms are practical ways to lower exposure. These steps are useful even when a child receives antibody protection.

Parents and caregivers can ask a pediatric clinician whether a child qualifies for a second season of nirsevimab and when it should be given. The CDC also recommends maternal RSV vaccination during pregnancy for eligible pregnancies as one way to protect newborns; recommendations depend on timing and individual circumstances. Families should follow current national guidance, since seasonal recommendations and eligibility can change.